The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03061266 |
Recruitment Status : Unknown
Verified February 2017 by Li-Li Chen, China Medical University Hospital.
Recruitment status was: Recruiting
First Posted : February 23, 2017
Last Update Posted : February 23, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Type 2 Diabetes Mellitus | Behavioral: E-health Education Other: Routine care | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 110 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Health Services Research |
Official Title: | The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes - Taking Local Teaching Hospital for Example |
Actual Study Start Date : | March 9, 2016 |
Estimated Primary Completion Date : | March 8, 2017 |
Estimated Study Completion Date : | March 8, 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: E-health education group
E-health education group will be received the shared care program using e-health education.
|
Behavioral: E-health Education
E-health education on shared care program will be established by different type's professionals including diabetes physicians, pharmacists, dietitians and diabetes health teacher. |
Routine care
Control group will be received the shared care program as advised by clinical professionals, which included medications, dietary control and general physical activities.
|
Other: Routine care
Routine care on shared care program as advised by clinical professionals, which included medications, dietary control and general physical activities. |
- Glycated hemoglobin (HbA1c) [ Time Frame: up to 6 months after the experiment ]glucose index
- Perceived diabetes self-management abilty using questionnaire [ Time Frame: baseline, 3 and 6 months after the experiment ]self-management abilty
- quality of life using questionnaire [ Time Frame: baseline, 3 and 6 months after the experiment ]the general well-being of individuals and societies, outlining negative and positive features of life

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- participation with type 2 diabetes mellitus received oral medication.
Exclusion Criteria:
- Studies were excluded from this study if participation had recently undergone serious operations, had a myocardial infarction, stroke, severe liver or kidney diseases, received injection medication,or any illness limiting participation in a physical activity program.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03061266
Contact: Chen Li-Li, PhD | +886-955741362 | lily@mail.cmu.edu.tw | |
Contact: Pai Lee-Wen, PhD | +886-955741362 | lwpai@ctust.edu.tw |
Taiwan | |
Puli Christian Hospital | Recruiting |
Nantou, Taiwan, 54510 | |
Contact: Chen Mei-Chih +886--49291-2151 pch@mail.pch.org.tw |
Study Director: | Chen Li-Li, PhD | China Medical University, Taichung, Taiwan | |
Principal Investigator: | Pai Lee-Wen, PhD | Department of Nursing, Central Taiwan University of Science and Technology, Taichung, Taiwan |
Publications of Results:
Other Publications:
Responsible Party: | Li-Li Chen, Principal Investigator, China Medical University Hospital |
ClinicalTrials.gov Identifier: | NCT03061266 History of Changes |
Other Study ID Numbers: |
CMUH105-REC2-013 |
First Posted: | February 23, 2017 Key Record Dates |
Last Update Posted: | February 23, 2017 |
Last Verified: | February 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
type 2 diabetes mellitus, application, e-health education |
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |